Xuqiang Zhu
First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, Glioma Diagnosis and Treatment, RNA Research and Splicing, Cerebrospinal fluid and hydrocephalus, MicroRNA in disease regulation
Most-Cited Works
- → Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer(2024)106 cited
- → Sangerbox 2: Enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform(2024)88 cited
- → Writers, readers, and erasers RNA modifications and drug resistance in cancer(2024)77 cited
- → Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1(2019)64 cited
- → miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2(2019)61 cited
- → FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis(2020)29 cited
- → Leveraging a disulfidptosis‑related lncRNAs signature for predicting the prognosis and immunotherapy of glioma(2023)26 cited
- → A novel signature of cuproptosis-related lncRNAs predicts prognosis in glioma: Evidence from bioinformatic analysis and experiments(2023)26 cited
- → <p>Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression</p>(2019)24 cited
- → LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma(2023)20 cited